Informed consent for HIV cure research in South Africa: issues to consider

Simple item page
dc.contributor.authorStaunton, Ciaraen_ZA
dc.date.accessioned2015-01-23T09:55:49Z
dc.date.available2015-01-23T09:55:49Z
dc.date.issued2015-01
dc.date.updated2015-01-21T04:03:03Z
dc.descriptionCITATION: Staunton, C. 2015. Informed consent for HIV cure research in South Africa: issues to consider. BMC Medical Ethics, 16:3, doi:10.1186/1472-6939-16-3.en_ZA
dc.descriptionThe original publication is available at http://www.biomedcentral.com/1472-6939/16/3en_ZA
dc.descriptionPublication of this article was funded by the Stellenbosch University Open Access Fund.
dc.description.abstractBackground South Africa has made great progress in the development of HIV/AIDS testing, treatment and prevention campaigns. Yet, it is clear that prevention and treatment campaigns alone are not enough to bring this epidemic under control. Discussion News that the “Berlin patient” and the “Mississippi baby” have both been “cured” of HIV brought hope to people living with HIV/AIDS in South Africa that a cure for HIV/AIDS is within reach. Despite the recent setbacks announced in the “Mississippi Baby” case, protocols aimed at curing HIV/AIDS are being developed in South Africa. However with evidence to suggest that participants in clinical trials do not understand the basic concepts in the informed consent process, there is concern that future participants in HIV/AIDS cure research will lack comprehension of the basic elements of future clinical trials that aims to cure HIV/AIDS and confuse research with clinical care. Summary Research ethics committees have an important role to play in ensuring that participants understand the basic concepts discussed in the informed consent process, that they understand that research is not clinical care and they are unlikely to benefit from any early phase trials seeking to cure HIV/AIDS.en
dc.description.versionPublishers' versionen_ZA
dc.identifier.citationStaunton, C. 2015. Informed consent for HIV cure research in South Africa: issues to consider. BMC Medical Ethics, 16:3, doi:10.1186/1472-6939-16-3.en_ZA
dc.identifier.issn1472-6939 (online)en_ZA
dc.identifier.otherdoi:10.1186/1472-6939-16-3en_ZA
dc.identifier.urihttp://hdl.handle.net/10019.1/96164
dc.language.isoen_ZAen
dc.publisherBioMed Centralen_ZA
dc.rights.holderCiara Staunton et al.; licensee BioMed Central Ltd.en_ZA
dc.subjectHIV/AIDSen_ZA
dc.subjectHIV/AIDS cureen_ZA
dc.subjectTherapeutic misconceptionen_ZA
dc.subjectAIDS (Disease) -- Treatment -- South Africa
dc.subjectAIDS (Disease) -- Patients -- Ethical aspects
dc.titleInformed consent for HIV cure research in South Africa: issues to consideren_ZA
dc.typeArticleen_ZA
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
1472-6939-16-3.xml
Size:
59.66 KB
Format:
Extensible Markup Language
Description:
Download
Thumbnail Image
Name:
1472-6939-16-3.pdf
Size:
189.71 KB
Format:
Adobe Portable Document Format
Description:
Download article
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.95 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Research Articles (Health Systems and Public Health)